Literature DB >> 28074400

Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

P Pérez-Segura1, J E Palacio2, L Vázquez3, S Monereo4, R de Las Peñas5, P Martínez de Icaya6, C Grávalos7, A Lecube8, A Blasco9, J M García-Almeida10, I Barneto11, A Goday12,13.   

Abstract

The relationship between obesity and cancer is clear and is present at all times during course of the disease. The importance of obesity in increasing the risk of developing cancer is well known, and some of the most prevalent tumours (breast, colorectal, and prostate) are directly related to this risk increase. However, there is less information available on the role that obesity plays when the patient has already been diagnosed with cancer. Certain data demonstrate that in some types of cancer, obese patients tolerate the treatments more poorly. Obesity is also known to have an impact on the prognosis, favouring lower survival rates or the appearance of secondary tumours. In this consensus statement, we will analyse the scientific evidence on the role that obesity plays in patients already diagnosed with cancer, and the available data on how obesity control can improve the quality of daily life for the cancer patient.

Entities:  

Keywords:  Cancer; Comorbidity; Morbid obesity; Mortality; Neoplasm recurrence; Obesity; Risk assessment; Survival rate

Mesh:

Year:  2017        PMID: 28074400     DOI: 10.1007/s12094-016-1601-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  65 in total

Review 1.  Nutrition and physical activity guidelines for cancer survivors.

Authors:  Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012-04-26       Impact factor: 508.702

2.  Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial.

Authors:  Kristin L Campbell; Karen E Foster-Schubert; Catherine M Alfano; Chia-Chi Wang; Ching-Yun Wang; Catherine R Duggan; Caitlin Mason; Ikuyo Imayama; Angela Kong; Liren Xiao; Carolyn E Bain; George L Blackburn; Frank Z Stanczyk; Anne McTiernan
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

Review 3.  Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study.

Authors:  J L Gutiérrez-Fisac; P Guallar-Castillón; L M León-Muñoz; A Graciani; J R Banegas; F Rodríguez-Artalejo
Journal:  Obes Rev       Date:  2011-12-12       Impact factor: 9.213

4.  The impact of obesity on breast cancer: a retrospective review.

Authors:  Danielle J Haakinson; Steven G Leeds; Amylou C Dueck; Richard J Gray; Nabil Wasif; Chee-Chee H Stucky; Donald W Northfelt; Heidi A Apsey; Barbara Pockaj
Journal:  Ann Surg Oncol       Date:  2012-03-27       Impact factor: 5.344

5.  American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity.

Authors:  Lawrence H Kushi; Colleen Doyle; Marji McCullough; Cheryl L Rock; Wendy Demark-Wahnefried; Elisa V Bandera; Susan Gapstur; Alpa V Patel; Kimberly Andrews; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012 Jan-Feb       Impact factor: 508.702

6.  ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.

Authors:  J Arends; G Bodoky; F Bozzetti; K Fearon; M Muscaritoli; G Selga; M A E van Bokhorst-de van der Schueren; M von Meyenfeldt; G Zürcher; R Fietkau; E Aulbert; B Frick; M Holm; M Kneba; H J Mestrom; A Zander
Journal:  Clin Nutr       Date:  2006-05-12       Impact factor: 7.324

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.

Authors:  Elizabeth J Folkerd; J Michael Dixon; Lorna Renshaw; Roger P A'Hern; Mitch Dowsett
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

9.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.

Authors:  Ivana Sestak; Wolfgang Distler; John F Forbes; Mitch Dowsett; Anthony Howell; Jack Cuzick
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

10.  Clinical comments related to medullary thyroid cancer diagnosis and management.

Authors:  Leonidas H Duntas
Journal:  Thyroid Res       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.